This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Matthew Brauer: Innovator in Biomarker Research
Introduction
Matthew Brauer is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical research, particularly in the identification of biomarkers for patient treatment. His work focuses on enhancing the effectiveness of therapies involving VEGF antagonists.
Latest Patents
Matthew Brauer holds a patent for "Biological markers for identifying patients for treatment with VEGF antagonists." This invention provides methods and compositions to detect the expression of one or more biomarkers that can identify and treat patients likely to respond to VEGF antagonist therapy. Additionally, the invention includes kits and articles of manufacture for use in these methods.
Career Highlights
Throughout his career, Matthew has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop innovative solutions that address critical healthcare challenges.
Collaborations
Matthew has collaborated with talented professionals in his field, including Mallika Singh and Carlos Bais. These partnerships have contributed to the advancement of research and the development of effective treatment strategies.
Conclusion
Matthew Brauer's work in biomarker research exemplifies the impact of innovation in medicine. His contributions are paving the way for improved patient care and treatment outcomes.